Conversely, a molar ratio greater than 2.0 leads to nonalcoholic fatty liver disease or steatohepatitis and disrupted insulin signaling; however, in our VDD model, we do not see nonalcoholic fatty liver disease or steatohepatitis (65, 66). The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.